Naloxone Hydrochloride Injection, Solution
Product Images NDC 67457-992

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 67457-992). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure diagram of Naloxone Hydrochloride Dihydrate, showing its molecular configuration along with chemical notation for hydrochloride and dihydrate components, accompanied by its chemical name and descriptors.*

FDA Label Image

Figure 1 (Image 02)

An instructional diagram of a prefilled syringe assembly for Naloxone Hydrochloride injection, solution 1 mg/mL by Mylan Institutional LLC. The diagram labels parts including the prefilled syringe, plunger rod, glass barrel, tip cap, and shows a 21G x 1½ inch needle with a protective cap, needle sheath, and hub.*

FDA Label Image

Figure 2 (Image 03)

An instructional illustration showing two hands; one hand holds a syringe upright while the other hand twists the cap off the syringe. The arrows indicate the direction to turn the cap for removal.*

FDA Label Image

Figure 3 (Image 04)

Instructional illustration showing hands removing a protective cover from a syringe, with an arrow indicating the direction to peel back the cover. The syringe contains a solution, likely representing preparation for injection administration.*

FDA Label Image

Figure 4 (Image 05)

An instructional illustration demonstrating the removal of a cap from a syringe assembly. A hand is pulling upward on the syringe cap while another hand holds the syringe barrel steady, showing steps likely related to preparing Naloxone Hydrochloride injectable solution for administration.*

FDA Label Image

Figure 5 (Image 06)

An instructional illustration showing a pair of hands preparing a prefilled syringe for injection. One hand holds the syringe barrel while the other pulls the plunger upward as indicated by an arrow, preparing the Naloxone Hydrochloride injection, solution for administration.*

FDA Label Image

Figure 6 (Image 07)

An instructional illustration showing three methods of activating a device: thumb activation, finger activation, and surface activation. Each panel displays a hand positioning differently to engage the device's activation lever or cover with arrows indicating the intended motion.*

FDA Label Image

Carton (Image 08)

Packaging label for Naloxone Hydrochloride Injection, USP 2 mg/2 mL (1 mg/mL) by Mylan Institutional LLC. The label states intramuscular, intravenous, and subcutaneous routes for use, single dose prefilled syringe with a 21-gauge needle included. The label provides storage instructions, usage warnings, and detailed syringe usage illustrations. Barcodes and manufacturing details from Mylan Institutional LLC, made in India, are present.*

FDA Label Image

Syringe Label (Image 09)

Label for Naloxone Hydrochloride Injection, USP 2 mg/2 mL (1 mg/mL) in a 2 mL single-dose prefilled syringe. The label indicates use for intramuscular, intravenous, or subcutaneous administration. Manufactured for Mylan Institutional LLC, Morgantown, WV, made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.